The FDA has granted emergency use authorization to a new saliva-based coronavirus test funded by the NBA and NBPA

Associated Press/Ashley Landis

• The US Food and Drug Administration granted emergency use authorization to a saliva-based coronavirus test funded by the NBA and NBPA to be made available for public use, the agency announced Saturday.
• Unlike most other coronavirus tests, which involve nasal swabs, the new SalivaDirect test simply processes saliva samples.
• The new test could cost as little as $4 dollars per sample and provide results within 24 hours, experts told ESPN.
• The saliva test was given to players along with other nasal swab tests to compare results, and Yale researchers found that both types of tests yielded nearly identical results. 
• Visit Business Insider's homepage for more stories.

On Saturday, the US Food and Drug Administration granted emergency use authorization to a saliva-based test funded by the NBA and National Basketball Players Association to be available for public use, the agency announced.

The test was developed by researchers at Yale and jointly funded by the NBA and NBPA, ESPN reported.See the rest of the story at Business Insider

NOW WATCH: Inside London during COVID-19 lockdown

See Also:

• California courts lift eviction and foreclosure moratorium. In the absence of a new law 365,000 households in the state are at risk of eviction.
• Meet Trump's new coronavirus adviser Dr. Scott Atlas, a Stanford physician who frequently criticized lockdown measures and believes in the full reopening of schools
• Germany's health minister expects there to be a coronavirus vaccine in the coming months and 'certainly' next year